RVNC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $540,043.76

Revance Therapeutics Insider Trading History Chart

Revance Therapeutics Share Price & Price History

^$34.43

▼ -0.49 (-1.40%)

As of 02/6/2023 05:10 PM ET

Days: 30 | 90 | 365

A gold storm is coming…

From Wall Street Watch Dogs | Ad

“We are in the early stages of a mania – the calm before the storm.”...

[Full Story]

Revance Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2023	Tobin Schilke	CFO	Sell	3,201	$34.60	$110,754.60	54,676
1/20/2023	Tobin Schilke	CFO	Sell	1,000	$31.00	$31,000.00	57,877
1/9/2023	Tobin Schilke	CFO	Sell	3,701	$27.16	$100,519.16	58,877
9/14/2022	Dwight Moxie	SVP	Sell	11,000	$27.07	$297,770.00	31,694
12/13/2021	Angus C. Russell	Director	Buy	6,400	$15.74	$100,736.00
12/3/2021	Aubrey Rankin	Insider	Buy	30,000	$14.43	$432,900.00
11/29/2021	Mark J. Foley	CEO	Buy	40,000	$12.90	$516,000.00
9/27/2021	Dwight Moxie	SVP	Sell	1,675	$30.00	$50,250.00
8/16/2021	Aubrey Rankin	Insider	Sell	9,364	$26.34	$246,647.76
7/28/2021	Aubrey Rankin	Insider	Sell	54,332	$30.06	$1,633,219.92	79,776
7/26/2021	Aubrey Rankin	Insider	Sell	55,382	$29.72	$1,645,953.04	79,776
4/5/2021	Aubrey Rankin	Insider	Sell	2	$28.28	$56.56	79,776
3/4/2021	Aubrey Rankin	Insider	Sell	33,119	$25.43	$842,216.17	79,776
2/1/2021	Aubrey Rankin	Insider	Sell	33,119	$25.95	$859,438.05	67,871
11/30/2020	Aubrey Rankin	Insider	Sell	33,119	$23.85	$789,888.15	67,871
10/29/2020	Aubrey Rankin	Insider	Sell	33,119	$26.15	$866,061.85	67,871
9/28/2020	Aubrey Rankin	Insider	Sell	33,119	$26.18	$867,055.42	67,871

"TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race

From Investing Trends | Ad

Did you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution.

Get the full story on this new opportunity

SEC Filings (Institutional Ownership Changes) for Revance Therapeutics (NASDAQ:RVNC)

82.68% of Revance Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revance Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/3/2023	Essex Investment Management Co. LLC	67,933	$1.25M	0.2%	-1.0%	0.083%
2/2/2023	SG Americas Securities LLC	7,462	$0.14M	0.0%	-34.6%	0.009%
2/2/2023	ProShare Advisors LLC	17,193	$0.32M	0.0%	+22.3%	0.021%
2/2/2023	Bfsg LLC	67,793	$1.25M	0.3%	N/A	0.082%
2/1/2023	State of New Jersey Common Pension Fund D	102,208	$1.89M	0.0%	-13.3%	0.124%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	13,871	$0.26M	0.0%	+76.0%	0.017%
2/1/2023	Legato Capital Management LLC	33,442	$0.62M	0.1%	N/A	0.041%
1/31/2023	Keybank National Association OH	15,030	$0.28M	0.0%	+61.8%	0.018%
1/30/2023	New York State Common Retirement Fund	52,608	$0.97M	0.0%	+4.0%	0.064%
1/27/2023	Rice Hall James & Associates LLC	875,496	$16.16M	0.9%	-2.4%	1.064%
1/26/2023	Inspire Investing LLC	12,798	$0.24M	0.0%	+66.4%	0.016%
1/24/2023	Moody Aldrich Partners LLC	114,173	$2.11M	0.4%	+42.7%	0.139%
1/23/2023	Waypoint Capital Advisors LLC	53,989	$1M	0.3%	N/A	0.066%
1/23/2023	Allspring Global Investments Holdings LLC	1,094,524	$20.21M	0.0%	+86.7%	1.330%
1/12/2023	Assenagon Asset Management S.A.	192,359	$3.55M	0.0%	-66.6%	0.234%
1/12/2023	DNB Asset Management AS	11,791	$0.22M	0.0%	N/A	0.014%
12/5/2022	Centaurus Financial Inc.	16,410	$0.44M	0.0%	-19.0%	0.020%
11/21/2022	California State Teachers Retirement System	97,856	$2.64M	0.0%	+10.9%	0.119%
11/16/2022	Glenmede Trust Co. NA	11,133	$0.30M	0.0%	N/A	0.014%
11/16/2022	Baird Financial Group Inc.	59,044	$1.59M	0.0%	N/A	0.072%
11/16/2022	Kingsview Wealth Management LLC	8,982	$0.24M	0.0%	N/A	0.011%
11/15/2022	State Street Corp	1,616,453	$43.64M	0.0%	-9.2%	1.965%
11/15/2022	Castleark Management LLC	138,347	$3.74M	0.2%	+7.0%	0.168%
11/15/2022	Jacobs Levy Equity Management Inc.	918,275	$24.79M	0.2%	+1,345.6%	1.116%
11/15/2022	Tang Capital Management LLC	287,500	$7.76M	1.0%	N/A	0.349%
11/15/2022	Two Sigma Advisers LP	507,500	$13.70M	0.0%	+368.2%	0.617%
11/15/2022	Two Sigma Investments LP	1,121,823	$30.29M	0.1%	+225.5%	1.364%
11/15/2022	UBS Asset Management Americas Inc.	69,815	$1.89M	0.0%	+1.4%	0.085%
11/15/2022	Vanguard Group Inc.	4,312,896	$116.45M	0.0%	+16.5%	5.242%
11/15/2022	Perceptive Advisors LLC	808,671	$21.83M	0.6%	+41.2%	0.983%
11/15/2022	Price T Rowe Associates Inc. MD	43,975	$1.19M	0.0%	+14.7%	0.053%
11/15/2022	Marshall Wace LLP	41,253	$1.12M	0.0%	+144.7%	0.050%
11/15/2022	Essex Investment Management Co. LLC	68,622	$1.85M	0.3%	+7.9%	0.083%
11/15/2022	Federated Hermes Inc.	96,146	$2.60M	0.0%	-20.8%	0.117%
11/15/2022	Commonwealth Equity Services LLC	75,825	$2.05M	0.0%	+131.1%	0.092%
11/14/2022	AlphaCrest Capital Management LLC	17,642	$0.48M	0.0%	-23.4%	0.021%
11/14/2022	Macquarie Group Ltd.	539	$35K	0.0%	-58.0%	0.001%
11/14/2022	LMR Partners LLP	100,000	$2.70M	0.0%	N/A	0.122%
11/14/2022	Cubist Systematic Strategies LLC	106,628	$2.88M	0.0%	-56.5%	0.130%
11/14/2022	Guggenheim Capital LLC	32,735	$0.88M	0.0%	-5.3%	0.040%
11/14/2022	PDT Partners LLC	45,800	$1.24M	0.2%	-58.6%	0.056%
11/14/2022	Boothbay Fund Management LLC	20,619	$0.56M	0.0%	N/A	0.025%
11/14/2022	HBK Investments L P	15,000	$0.41M	0.0%	N/A	0.018%
11/14/2022	Ergoteles LLC	26,709	$0.72M	0.0%	N/A	0.032%
11/14/2022	Nuveen Asset Management LLC	619,164	$16.72M	0.0%	+72.4%	0.753%
11/14/2022	Integral Health Asset Management LLC	150,000	$4.05M	0.8%	N/A	0.182%
11/14/2022	Princeton Global Asset Management LLC	2,500	$68K	0.0%	N/A	0.003%
11/14/2022	Metropolitan Life Insurance Co NY	4,315	$0.12M	0.0%	-9.6%	0.005%
11/14/2022	Ghost Tree Capital LLC	390,000	$10.53M	3.0%	N/A	0.474%
11/14/2022	Hennion & Walsh Asset Management Inc.	84,259	$2.28M	0.1%	-5.3%	0.102%
11/10/2022	Envestnet Asset Management Inc.	14,310	$0.39M	0.0%	+34.1%	0.020%
11/10/2022	Evolutionary Tree Capital Management LLC	191,868	$5.18M	5.0%	+43.0%	0.262%
11/10/2022	Credit Suisse AG	97,253	$2.63M	0.0%	+7.0%	0.133%
11/10/2022	WINTON GROUP Ltd	10,150	$0.27M	0.0%	N/A	0.014%
11/10/2022	Tower Research Capital LLC TRC	5,214	$0.14M	0.0%	+54.1%	0.007%
11/10/2022	UBS Group AG	82,762	$2.23M	0.0%	-4.8%	0.113%
11/9/2022	Amalgamated Bank	11,607	$0.31M	0.0%	+5.0%	0.016%
11/9/2022	Picton Mahoney Asset Management	61,400	$1.66M	0.1%	N/A	0.084%
11/9/2022	Blair William & Co. IL	110,305	$2.98M	0.0%	+677.2%	0.151%
11/9/2022	Mark Sheptoff Financial Planning LLC	2,000	$54K	0.0%	N/A	0.003%
11/8/2022	International Biotechnology Trust PLC	120,000	$3.24M	1.0%	N/A	0.164%
11/8/2022	Exencial Wealth Advisors LLC	9,045	$0.24M	0.0%	N/A	0.012%
11/7/2022	Inspire Investing LLC	7,689	$0.21M	0.0%	-50.5%	0.011%
11/7/2022	Rothschild & Co. Asset Management US Inc.	214,935	$5.80M	0.1%	-0.7%	0.294%
11/7/2022	Quantbot Technologies LP	5,136	$0.14M	0.0%	N/A	0.007%
11/7/2022	Jump Financial LLC	68,200	$1.84M	0.1%	-2.4%	0.093%
11/7/2022	ProShare Advisors LLC	14,057	$0.38M	0.0%	+3.8%	0.019%
11/4/2022	First Republic Investment Management Inc.	37,507	$1.01M	0.0%	+34.1%	0.051%
11/3/2022	CIBC Asset Management Inc	501,169	$13.53M	0.1%	N/A	0.686%
11/3/2022	Teacher Retirement System of Texas	9,907	$0.27M	0.0%	-5.7%	0.014%
11/3/2022	The Manufacturers Life Insurance Company	27,437	$0.74M	0.0%	-1.8%	0.038%
11/3/2022	Barclays PLC	93,930	$2.54M	0.0%	+107.8%	0.128%
11/3/2022	Flaharty Asset Management LLC	12,452	$0.34M	0.1%	-28.7%	0.017%
11/2/2022	Victory Capital Management Inc.	40,540	$1.09M	0.0%	N/A	0.055%
11/1/2022	Rice Hall James & Associates LLC	896,754	$24.21M	1.4%	-17.4%	1.227%
11/1/2022	Monashee Investment Management LLC	85,000	$2.30M	0.9%	N/A	0.116%
11/1/2022	Jennison Associates LLC	1,072,235	$28.95M	0.0%	-38.9%	1.467%
10/31/2022	SG Americas Securities LLC	11,402	$0.31M	0.0%	N/A	0.016%
10/28/2022	State of New Jersey Common Pension Fund D	117,907	$3.18M	0.0%	N/A	0.161%
10/28/2022	NJ State Employees Deferred Compensation Plan	17,900	$0.48M	0.1%	N/A	0.024%
10/27/2022	US Bancorp DE	16,999	$0.46M	0.0%	+1,895.2%	0.023%
10/27/2022	Keybank National Association OH	9,290	$0.25M	0.0%	-28.1%	0.013%
10/27/2022	Assenagon Asset Management S.A.	575,564	$15.54M	0.1%	+340.5%	0.787%
10/27/2022	Handelsbanken Fonder AB	9,500	$0.26M	0.0%	N/A	0.013%
10/26/2022	Allspring Global Investments Holdings LLC	586,275	$15.83M	0.0%	+151,392.2%	0.802%
10/25/2022	Denali Advisors LLC	4,500	$0.12M	0.1%	-18.2%	0.006%
10/18/2022	Moody Aldrich Partners LLC	79,984	$2.16M	0.4%	N/A	0.109%
9/16/2022	Federated Hermes Inc.	121,400	$1.68M	0.0%	N/A	0.166%
8/22/2022	ExodusPoint Capital Management LP	71,966	$1M	0.0%	N/A	0.098%
8/19/2022	Walleye Capital LLC	464,970	$6.43M	0.2%	-8.1%	0.636%
8/18/2022	Goldman Sachs Group Inc.	828,925	$11.46M	0.0%	+26.3%	1.134%
8/16/2022	First Republic Investment Management Inc.	27,978	$0.39M	0.0%	-67.1%	0.038%
8/16/2022	Castleark Management LLC	129,313	$1.79M	0.1%	N/A	0.177%
8/16/2022	Prudential Financial Inc.	52,084	$0.72M	0.0%	-61.6%	0.071%
8/16/2022	Corton Capital Inc.	11,736	$0.16M	0.2%	N/A	0.016%
8/16/2022	Delphia USA Inc.	12,881	$0.18M	0.1%	N/A	0.018%
8/15/2022	Occudo Quantitative Strategies LP	43,769	$0.61M	0.0%	N/A	0.060%
8/15/2022	Palo Alto Investors LP	4,405,039	$60.88M	5.3%	-0.2%	6.026%
8/15/2022	State Street Corp	1,779,793	$24.60M	0.0%	+15.5%	2.435%
8/15/2022	PDT Partners LLC	110,690	$1.53M	0.1%	N/A	0.151%

Data available starting January 2016

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.

Today's Range

Now: $34.43

$34.12

$35.51

50 Day Range

MA: $24.70

$18.32

$35.27

52 Week Range

Now: $34.43

$11.27

$35.99

Volume

597,375 shs

Average Volume

2,118,003 shs

Market Capitalization

$2.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87

Who are the company insiders with the largest holdings of Revance Therapeutics?: Revance Therapeutics' top insider investors include:
Aubrey Rankin (Insider)
Tobin Schilke (CFO)
Dwight Moxie (SVP)
Angus C Russell (Director)
Mark J Foley (CEO)
Learn More about top insider investors at Revance Therapeutics.
Who are the major institutional investors of Revance Therapeutics?: Revance Therapeutics' top institutional investors include:
Allspring Global Investments Holdings LLC — 1.33%
Rice Hall James & Associates LLC — 1.06%
Assenagon Asset Management S.A. — 0.23%
Moody Aldrich Partners LLC — 0.14%
State of New Jersey Common Pension Fund D — 0.12%
Essex Investment Management Co. LLC — 0.08%
Learn More about top institutional investors of Revance Therapeutics stock.
Which major investors are selling Revance Therapeutics stock?: During the last quarter, RVNC stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Simplex Trading LLC
Rice Hall James & Associates LLC
State of New Jersey Common Pension Fund D
SG Americas Securities LLC
Essex Investment Management Co. LLC
Within the previous year, company insiders that have sold Revance Therapeutics company stock include:
Aubrey Rankin (Insider)
Tobin Schilke (CFO)
Learn More investors selling Revance Therapeutics stock.
Which major investors are buying Revance Therapeutics stock?: Within the last quarter, RVNC stock was purchased by institutional investors including:
Allspring Global Investments Holdings LLC
Bfsg LLC
Waypoint Capital Advisors LLC
Moody Aldrich Partners LLC
Legato Capital Management LLC
DNB Asset Management AS
Zurcher Kantonalbank Zurich Cantonalbank
Keybank National Association OH
Within the previous year, these company insiders have bought Revance Therapeutics stock:
Aubrey Rankin (Insider)
Tobin Schilke (CFO)
Dwight Moxie (SVP)
Learn More investors buying Revance Therapeutics stock.